We planned the experiment in accordance with the goal of evaluating the impact of astrocyte-derived proteins on the neurons’ gene network and of identifying the differences between HD and PARK2-mutant neurons in their interactions with glial soluble factors of HD and PD patients. The gene discussed is PRKN; the disease is Parkinson disease.